Hopp til innholdet
innsidehandel

← Alle transaksjoner

Thor Medical ASA: Notification of trade for close associates of primary insider

Thor Medical ASA (TRMED) · publisert 9. april 2025 kl. 15:19 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplass
John Andersen via Scatec Invest IV ASStyremedlemAnnet Uklassifisert2 811 4672,25 NOK9. april 2025NO0010597883Outside trading venue
John Andersen via Scatec Innovation ASStyremedlemAnnet Uklassifisert417 0532,25 NOK9. april 2025NO0010597883Outside trading venue
Brede Høyland Ellingsæter via B good industries ASAnnet Uklassifisert1 081 3462,25 NOK9. april 2025NO0010597883Outside trading venue

Vedlegg

Meldingstekst

9.4.2025 15:19:54 CEST | Thor Medical ASA | Mandatory notification of trade primary insiders Oslo, Norway, 9 April 2025: Scatec Invest IV, a close associate of Thor Medical board member John Andersen, has resolved a dividend of shares in Thor Medical ASA to its shareholders, including to close associates of primary insiders CFO Brede Ellingsæter and board member John Andersen in Thor Medical ASA. Scatec Invest IV has distributed a total of 2,811,467 shares in Thor Medical ASA as dividend, based on a share price of NOK 2,25 per share. As a result of the distribution, primary insiders have increased their controlled holding of shares in Thor Medical ASA through their close associates. B good industries AS, a close associate of Thor Medical ASA CFO Brede Ellingsæter, has received 1,081,346 shares. Scatec Innovation AS, a close associate of Thor Medical board member John Andersen, has received 417,053 shares. Following the distribution, CFO Brede Ellingsæter controls 1,481,346 shares and holds 3,100,000 share options in Thor Medical. Primary insider notifications pursuant to the market abuse regulation article 19 are attached. This information is subject to disclosure requirements pursuant to the EU Market Abuse Regulation article 5 and the Norwegian Securities Trading Act section 5-12. Contacts Gisle Bjørnstad, CFO, Scatec Innovation AS, +47 95142892, gisle.bjornstad@scatec.no ABOUT THOR MEDICAL ASA Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn more, visit www.thormedical.no - http://www.thormedical.no - https://www.thormedical.no. ATTACHMENTS Download announcement as PDF.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18491057/5930/Download%20announce ment%20as%20PDF.pdf 20250409 - MAR - Primary insider notifications - Scatec Invest IV AS B Good industries AS and Scatec Innovation AS.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18491057/5929/20250409%20-%20MAR% 20-%20Primary%20insider%20notifications%20-%20Scatec%20Invest%20IV%20AS%20B%20Go od%20industries%20AS%20and%20Scatec%20Innovation%20AS.pdf